Advertisement

Topics

Cambria Biosciences Company Profile

12:33 EST 20th November 2017 | BioPortfolio

Cambria Biosciences was founded in December 1998 to apply genomic model organism systems to discover new products for controlling economically important insect and nematode pests and parasites. Our approach targets molecules and cellular processes that are restricted to invertebrates, leading to screens and lead compounds that can address key plant and animal pests and parasites in a highly selective manner, enhancing the development of products with novel modes of action and highly desirable safety parameters. Our company aims to establish corporate partnerships to utilize its proprietary technology platform for pharmaceutical or agrichemical target discovery and validation.

Location

2 Bedford Court
Bedford
MA
01730
United States of America

Contact

Phone: 781 275 2800
Fax: 781 275 6788
Email: info@cambriabio.com


News Articles [576 Associated News Articles listed on BioPortfolio]

Harmony Biosciences gains US rights to pitolisant; raises $270 million

USA-based Harmony Biosciences, a part of the Paragon Biosciences corporate family, has acquired the exclusive…

Ricerca Biosciences, LLC Renamed to Concord Biosciences, LLC After Sale of Chemical Development ...

According to Clifford W. Croleyof Main Market Partners and the CEO of Concord Biosciences, "We are very pleased to focus our complete energies Read more...

Apricus Biosciences, Inc.: Apricus Biosciences to Present at the 2017 BIO Investor Forum

SAN DIEGO, 2017-10-10 13:00 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced...

Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo ...

http://dailystocktracker.com/register/ Apricus Biosciences  On Tuesday, shares in San Diego, Californiaheadquartered Apricus Biosciences Inc. recorded a trading volume of 128,247 shares. The stoc...

Head to Head Survey: DARA Biosciences

DARA Biosciences and Mallinckrodt PLC are both specialty & advanced pharmaceuticals companies, but which is the superior investment? We will contrast the two companies based on the strength of the...

Reviewing Catalyst Biosciences

Catalyst Biosciences and Fortress Biotech are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valu...

Catalyst Biosciences and Mosaic Biosciences Enter into Strategic Collaboration to Develop Intravitreal Anti-Complement Factor 3 (C3) Products for the Treatment of Dry AMD and Other Retinal Diseases

Collaboration aims to develop best-in-class anti-C3 intravitreal products with quarterly dosing frequency and better potency C3 is a clinically validated target in dry age-related macular degener...

Mallinckrodt PLC (MNK) versus DARA Biosciences (DARA) Head-To-Head Contrast

Mallinckrodt PLC and DARA Biosciences are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, instituti...

PubMed Articles [67 Associated PubMed Articles listed on BioPortfolio]

Draft Genome Sequences of Trichophyton rubrum CMCC(F)T1i and Trichophyton violaceum CMCC(F)T3l by Illumina 2000 and Pacific Biosciences.

One strain of Trichophyton rubrum CMCC(F)T1i (=CBS 139224) isolated from onychomycosis and one strain of Trichophyton violaceum CMCC(F)T3l (=CBS 141829) isolated from tinea capitis in China were whole...

Amnesia and criminal responsibility.

Front cover.

Front cover.

Back cover.

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Cell-mediated immunity (CMI) and in particular T cells play a critical role in the rejection of transplanted organs. Thus, in transplant recipients a life-long and individualized immunosup...

Companies [345 Associated Companies listed on BioPortfolio]

Cambria Biosciences

Cambria Biosciences was founded in December 1998 to apply genomic model organism systems to discover new products for controlling economically important insect and nematode pests and parasites. Our ap...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

More Information about "Cambria Biosciences" on BioPortfolio

We have published hundreds of Cambria Biosciences news stories on BioPortfolio along with dozens of Cambria Biosciences Clinical Trials and PubMed Articles about Cambria Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambria Biosciences Companies in our database. You can also find out about relevant Cambria Biosciences Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record